Bill > HB2067

This bill modifies the prescriptive authority of advanced practice registered nurses (APRNs) by expanding their ability to prescribe controlled substances and clarifying the terms of collaborative practice arrangements with physicians. Specifically, the bill allows APRNs with a certificate of controlled substance prescriptive authority to prescribe Schedule III, IV, and V controlled substances, and grants them limited authority to prescribe certain Schedule II medications, including hydrocodone, Schedule II controlled substances for hospice patients, and Schedule II stimulants. The bill establishes detailed requirements for collaborative practice arrangements, including provisions for geographic proximity, chart reviews, and the maximum number of APRNs a physician can collaborate with (six full-time equivalent providers). The legislation also allows APRNs to prescribe buprenorphine for up to 30 days for patients receiving medication-assisted treatment for substance use disorders and provides specific guidelines for how physicians and APRNs must work together, such as requiring periodic chart reviews, maintaining documentation, and ensuring that the prescribing is consistent with the nurse's education and competence. Additionally, the bill protects both physicians and APRNs by allowing them to refuse collaboration without penalty and ensures that collaborative arrangements do not override existing hospital medication protocols.

https://house.mo.gov/Bill.aspx?bill=HB2067&year=2026&code=R